MOLN
Molecular Partners AG
NASDAQ · Healthcare · Biotechnology · CH
$4.29
−1.38%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -1.11x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.05x
- Net debt / EBITDA
- 1.17x
Liquidity & coverage
- Current ratio
- 7.27x
- Quick ratio
- 7.27x
- Cash ratio
- 6.92x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $76.0M
Cash & dividend
- FCF / debt
- -17.08x
- Cash flow / debt
- -16.99x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026